MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -81.8% | 32,533 | -21.3% | 0.00% | – |
| Q4 2021 | $110,000 | -54.9% | 41,312 | -53.3% | 0.00% | -100.0% |
| Q3 2021 | $244,000 | -16.2% | 88,389 | -13.3% | 0.00% | 0.0% |
| Q2 2021 | $291,000 | +293.2% | 101,993 | +262.4% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | -77.2% | 28,146 | -72.9% | 0.00% | -75.0% |
| Q3 2020 | $324,000 | +86.2% | 103,701 | +146.8% | 0.00% | +33.3% |
| Q2 2020 | $174,000 | +41.5% | 42,023 | -45.1% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | -37.6% | 76,503 | -3.9% | 0.00% | +200.0% |
| Q4 2019 | $197,000 | +657.7% | 79,614 | +536.9% | 0.00% | – |
| Q1 2018 | $26,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |